Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03095781 |
Title | Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Emory University |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Emory University Hospital Midtown | Atlanta | Georgia | 30308 | United States | Details | |
Emory University/Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
Emory Saint Joseph's Hospital | Atlanta | Georgia | 30342 | United States | Details |